ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
31 hedge funds and large institutions have $47.2M invested in Elevation Oncology in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
57% less capital invested
Capital invested by funds: $110M → $47.2M (-$63M)
Holders
31
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.77M | |
| 2 | +$277K | |
| 3 | +$142K | |
| 4 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
+$75.3K |
| 5 |
B
Bailard
Foster City,
California
|
+$59K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$132K | |
| 3 | -$126K | |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$86K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$82K |